Hemolytic anemia happens when red blood cells are destroyed faster than your bone marrow can replace them. Unlike other forms of anemia where the body simply doesn’t produce enough red blood cells, hemolytic anemia involves the premature breakdown of cells that were already circulating. The causes range from inherited genetic conditions to infections, medications, and even mechanical damage from artificial heart valves.
How Red Blood Cells Get Destroyed
Red blood cells normally live about 120 days before being recycled by the body. In hemolytic anemia, that lifespan is cut short through one of two pathways. Understanding which one is at play helps explain the symptoms you might notice.
In extravascular hemolysis, the more common form, the spleen and liver filter out red blood cells that are damaged, misshapen, or coated with antibodies. The spleen is especially good at catching cells that can’t flex and squeeze through its narrow passages. When red blood cells are too rigid or abnormally shaped, they get trapped and broken down. This is why the spleen often enlarges in people with chronic hemolytic anemia: it’s working overtime to clear defective cells.
In intravascular hemolysis, red blood cells rupture right inside the bloodstream. This happens when cell membranes are severely damaged by immune reactions, physical shearing forces, toxins (like those from certain bacterial infections or venomous snake bites), or clotting disorders. When cells burst in the bloodstream, they release hemoglobin directly into the plasma. The body has a binding protein called haptoglobin that mops up free hemoglobin, but during active intravascular hemolysis, haptoglobin gets used up quickly. Excess hemoglobin then spills into the urine, sometimes turning it dark red or brown.
Inherited Causes
Genetic hemolytic anemias fall into three broad categories based on which part of the red blood cell is affected: the hemoglobin inside it, the membrane surrounding it, or the enzymes that keep it functioning.
Hemoglobin Disorders
Sickle cell disease is the most well-known example. The hemoglobin inside these red blood cells is abnormal, causing the cells to become rigid and crescent-shaped under stress. Because they can’t flex to pass through the spleen’s tight filtering system, they get trapped and destroyed. Thalassemia, another hemoglobin disorder, causes the body to produce unstable hemoglobin chains that damage red blood cells from the inside.
Membrane Disorders
Some people inherit defects in the proteins that form the red blood cell’s outer membrane. In hereditary spherocytosis, cells lose their normal disc shape and become small, round spheres that the spleen removes aggressively. In hereditary elliptocytosis, cells are oval or elongated. Other rarer membrane conditions, like hereditary xerocytosis and overhydrated stomatocytosis, affect how water and ions move across the cell membrane, making the cells either too dehydrated or too waterlogged to survive normally.
Enzyme Deficiencies
Red blood cells rely on specific enzymes to protect themselves from oxidative damage. G6PD deficiency, one of the most common enzyme disorders worldwide, leaves red blood cells vulnerable to destruction when exposed to certain triggers like infections, fava beans, or particular medications. During an acute episode, bilirubin levels can spike above 4 mg/dL as massive numbers of cells break down at once. Pyruvate kinase deficiency is another enzyme disorder that starves red blood cells of energy, shortening their lifespan.
Autoimmune Hemolytic Anemia
In autoimmune hemolytic anemia (AIHA), the immune system mistakenly produces antibodies that target the body’s own red blood cells. This is one of the more common acquired causes, with an estimated incidence of roughly 1.4 to 6.6 new cases per 100,000 people per year in the United States, depending on the population studied.
There are two main types, defined by what temperature activates the destructive antibodies. Warm AIHA involves IgG antibodies that attach to red blood cells at normal body temperature. These antibody-coated cells are then cleared by the spleen and liver. Warm AIHA is the more common form and can occur on its own or alongside autoimmune diseases like lupus, where hemolytic anemia affects up to 10% of patients.
Cold agglutinin disease involves IgM antibodies that bind to red blood cells at cooler temperatures, typically in the extremities like fingers, toes, and ears. These antibodies latch onto sugar molecules on the red blood cell surface, causing the cells to clump together and break apart. Symptoms often flare in cold weather or after handling cold objects.
Medications That Trigger Hemolysis
Certain drugs can provoke the immune system into attacking red blood cells. This is called drug-induced immune hemolytic anemia, and it can develop even after you’ve taken the medication safely for weeks or months. Cephalosporin antibiotics are the most common cause. Other medications linked to this reaction include penicillin and its derivatives, certain fluoroquinolone antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDs), levodopa (used for Parkinson’s disease), and nitrofurantoin (a urinary tract infection antibiotic).
The hemolysis typically resolves after the triggering medication is stopped, though it can take time for antibody levels to fall and red blood cell counts to recover.
Infections That Destroy Red Blood Cells
Several infections directly attack or damage red blood cells. Malaria is the most significant globally. The Plasmodium parasite invades red blood cells, replicates inside them, and eventually ruptures them to spread to new cells. The spleen also clears both parasitized and damaged uninfected cells from circulation, compounding the anemia. Babesiosis, a tick-borne illness caused by a related parasite, works through a similar mechanism.
Certain bacterial infections contribute to hemolysis through toxins. Clostridial bacteria, for example, produce toxins that directly destroy red blood cell membranes. In children with malaria, the combination of hemolytic anemia and immune suppression also increases vulnerability to secondary bacterial infections.
Mechanical and Physical Causes
Red blood cells can be physically sheared apart by abnormal forces in the circulatory system. Prosthetic heart valves are a well-recognized cause, with hemolytic anemia reported in approximately 15% of people with valve replacements. Mechanical valves are more prone to causing this than biological tissue valves, and aortic valves cause more hemolysis than mitral valves. The destruction happens when blood jets slam into the hard surface of the prosthesis or squeeze through small gaps where the valve doesn’t seal perfectly. The severity depends on the level of shear stress, not the specific location of any leak.
Blood smears from these patients show schistocytes, which are fragmented pieces of red blood cells that have been sliced apart by turbulent flow. The same type of fragmentation occurs in thrombotic microangiopathies, conditions where tiny blood clots form in small vessels and act like blades that shred passing red blood cells. This includes conditions like thrombotic thrombocytopenic purpura (TTP), disseminated intravascular coagulation, and HELLP syndrome during pregnancy.
Even direct physical trauma can cause hemolysis. March hemoglobinuria, seen in long-distance runners and soldiers on extended marches, results from repeated impacts destroying red blood cells in the feet. There are even documented cases of hemolysis in conga drum players from the repetitive striking force on their hands.
How Hemolytic Anemia Shows Up
Regardless of the cause, the body’s response to accelerated red blood cell destruction produces a recognizable pattern. Jaundice, a yellowing of the skin and eyes, develops because broken-down hemoglobin is converted to bilirubin faster than the liver can process it. In most hemolytic conditions, bilirubin levels stay below 4 mg/dL unless there’s an acute crisis or the liver is already compromised.
The bone marrow ramps up production of new red blood cells to compensate, releasing immature cells called reticulocytes into the bloodstream. In chronic hemolytic conditions, the reticulocyte count stays mildly elevated. During an acute crisis, it can spike dramatically. However, if the bone marrow is itself affected by infection, nutritional deficiencies, or autoimmune damage to precursor cells, this compensatory response can fail, and the anemia worsens rapidly.
How Hemolysis Is Confirmed
If you’re being evaluated for hemolytic anemia, a few blood tests form the diagnostic backbone. Haptoglobin, the protein that binds free hemoglobin, drops significantly during active hemolysis. A level of 25 mg/dL or less identifies hemolytic disease with about 83% sensitivity and 96% specificity. In autoimmune hemolytic anemia specifically, haptoglobin is the most sensitive marker and the last to return to normal after recovery, sometimes staying low even after hemoglobin levels have normalized.
LDH, an enzyme released from damaged cells, rises during hemolysis. The degree of elevation helps distinguish the type: it’s mildly elevated in extravascular hemolysis (like warm autoimmune disease or inherited conditions) but climbs to four or five times the upper normal limit in intravascular hemolysis (like that caused by prosthetic valves or paroxysmal nocturnal hemoglobinuria). Unconjugated bilirubin rises as a byproduct of hemoglobin breakdown. A direct antiglobulin test (sometimes called a Coombs test) can confirm whether antibodies are coating the red blood cells, pointing toward an autoimmune or drug-induced cause.